Envestnet Asset Management Inc Chemomab Therapeutics Ltd. Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$1.9 - $3.2 $2,175 - $3,664	1,145 Added 9.77%	12,861 $41,000
Q3 2022 Nov 10, 2022	SELL	$2.33 - $4.0 $1,111 - $1,908	-477 Reduced 3.91%	11,716 $29,000
Q2 2022 Aug 03, 2022	BUY	$2.58 - $4.88 $3,575 - $6,763	1,386 Added 12.83%	12,193 $45,000
Q1 2022 May 04, 2022	BUY	$3.53 - $7.2 $38,148 - $77,810	10,807 New	10,807 $52,000

4.55M

Ticker CMMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,431,700
Market Cap $18.9M
Description
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.